IMERYS (EPA:NK) - Imerys Talc America Inc. (ITA) to appeal jury verdict in Lanzo trial
Transparency directive : regulatory news
12/04/2018 23:30
Click here to download pdf version
PRESS RELEASEROSWELL, GEORGIA, APRIL 12, 2018
Imerys Talc America Inc. (ITA) to appeal jury verdict in Lanzo trial
ITA will appeal the decision of a New Jersey jury that found it and Johnson &
Johnson responsible for a New Jersey resident's lung disease. Mr. Lanzo has
mesothelioma, a form of lung cancer often linked with asbestos exposure. The
jury awarded him and his wife compensatory and punitive damages, of which ITA
share is $36.1M.
While ITA deeply sympathizes with those affected by all forms of cancer, this
decision is inconsistent with a great deal of science establishing the safety
of talc, including a recently published study of workers who mined and milled
talc. It is also inconsistent with previous juries addressing the same issues,
which did not find ITA's products contained asbestos or caused any disease.
ITA follows all Food and Drug Administration (FDA) and other regulatory
guidelines and utilizes rigorous testing to ensure that Imerys talc meets the
highest quality standards.
ITA is confident its products are safe. ITA and its insurers are defending
lawsuits in several jurisdictions across the country, and it will continue to
vigorously defend itself against such possible claims in the future.
About ITA
Imerys Talc America is the leading talc producer on the American continent,
with operations in Montana, Vermont, and Texas.
The company supplies premium-quality, talc-based solutions to a wide variety of
industrial applications including paints, plastics, ceramics, rubber, paper,
agriculture, adhesives and sealants, building products, cosmetics and
pharmaceuticals.(www.imerystalc.com).
Press Contacts:
Dan Rene at (202) 973-1325
www.imerys.com
IMERYS's latest news
11/04/2024 18:00
05/04/2024 17:55
04/04/2024 17:55
28/03/2024 08:45
26/03/2024 19:40
08/03/2024 18:15
26/02/2024 18:00
21/02/2024 18:07
31/01/2024 17:45
21/12/2023 18:00
Other stories
18/04/2024 19:24
18/04/2024 19:37
18/04/2024 14:23
18/04/2024 16:35
17/04/2024 22:30
18/04/2024 17:13
18/04/2024 14:08
18/04/2024 11:51
18/04/2024 19:04
18/04/2024 17:59
18/04/2024 15:58
18/04/2024 16:37
18/04/2024 13:21
18/04/2024 17:34
18/04/2024 18:49
18/04/2024 15:16
18/04/2024 10:13
18/04/2024 19:13
18/04/2024 12:26
18/04/2024 12:46
18/04/2024 17:33
18/04/2024 14:11
18/04/2024 12:57
18/04/2024 19:26
18/04/2024 13:30
18/04/2024 14:54
18/04/2024 19:33
18/04/2024 19:13
18/04/2024 11:23
18/04/2024 20:19
18/04/2024 07:11
18/04/2024 14:41
18/04/2024 11:30
17/04/2024 09:30
18/04/2024 19:24
18/04/2024 14:37
18/04/2024 12:50
18/04/2024 00:30